"We are poised to make exceptional contributions to cancer research and expand knowledge of disease diversity." ~ Dr. Melissa Davis, ITGM Director 

Institute Goals

The goals of the ITGM are two-fold; to provide genomic research capacity to ͼ researchers across the existing research centers and institutes, and to provide leadership and increase our knowledge of genetic variation across the African diaspora and its impact on heath and disease.

Five-Year Plan

  • Year 1: Includes establishment of AC core leadership and specialty teams, the initialization of installation and optimization of internal pipeline for analytical needs, establishment of the first 2-year term EAB, first NYGC workshop, initial data repository. Projects will complete 15-20% of data generation in preliminary findings. Community education events will be established and fellowship recruitment for summer programs. 
     
  • Year 2: Includes initial genomics certification ( 3-course program), scaffold for repositories will be complete and ready for real-tim depository, initial landmark papers are expected from each project, continuing data generation evaluations of all courses 

  • Year 3: Establishment of second EAB term, Web-based self-paced coursework online, project 2 will release new pangenomes for African Ancestry population, revamped community education and pipeline activities initiated, second cohort of fellows will begin. 

  • Year 4: Third cohort of fellows will begin, project 1 will complete social determinants capture for entire target cohort, data repositories will be completed, and second (revamped) of 3-course genomics curriculum will be initiated. 

  • Year 5: Closing of all evaluations, summary publications, dissemination materials for health advocacy and interventions, established pipeline for best practices in disparities research for the African diaspora​. 

Administration

Cancer geneticist Dr. Melissa Davis serves as the inaugural ITGM director, in collaboration with associate director Dr. Robert Meller. A leader in transformative research, patient advocacy, and global health equity, Dr. Davis is a Distinguished Investigator with the Georgia Research Alliance. She also serves as Scientific Director of the International Center for the Study of Breast Cancer Subtypes (ICSBCS), Interim Director of Health Equity for the Englander Institute of Precision Medicine, and Associate Professor of Cell and Developmental Biology at Weill Cornell Medicine in New York, NY. She is also a Cancer Ethnicity Scholar, co-leading the PolyEthnic-1000 project at the New York Genome Center. 

Dr. Melissa Davis Dr. Robert Meller
Dr. Melissa Davis, PhD
Director, ͼ Institute of Translational
Genomic Medicine (ITGM)

Dr. Robert Meller, D.Phil. BSc
Associate Director, ͼ Institute of
Translational Genomic Medicine (ITGM)